The Library
Group-sequential methods for adaptive seamless phase II/III clinical trials
Tools
Stallard, Nigel. (2011) Group-sequential methods for adaptive seamless phase II/III clinical trials. Journal of Biopharmaceutical Statistics, Vol.21 (No.4). pp. 787-801. ISSN 1054-3406
Full text not available from this repository.
Official URL: http://dx.doi.org/10.1080/10543406.2011.551335
Abstract
The last 10 years have seen considerable interest in clinical trial designs that allow the seamless combination of Phases II and III in a single clinical trial. Such designs bring together the selection of the most promising of a number of treatments, as usually performed in a Phase II clinical trial, with the rigorous analysis and control of type I error rates required for a Phase III clinical trial. Statistically, the challenge is that of allowing for multiple comparisons arising both from repeated analyses of the accumulating data and from selection of a treatment on the basis of data that will be included in the final analysis. This challenge can be met in a number of different ways. This paper reviews methods based on the group-sequential methodology for monitoring of sequential clinical trials. The main focus of the paper will be a description of the methodology, including the setting in which short-term data are used for decision making at an early interim analysis.
| Item Type: | Journal Article |
|---|---|
| Subjects: | Q Science > QA Mathematics R Medicine > R Medicine (General) |
| Divisions: | Faculty of Medicine > Warwick Medical School > Health Sciences Faculty of Medicine > Warwick Medical School |
| Library of Congress Subject Headings (LCSH): | Clinical trials -- Design, Clinical trials -- Statistical methods, Therapeutics -- Testing |
| Journal or Publication Title: | Journal of Biopharmaceutical Statistics |
| Publisher: | Taylor & Francis Inc. |
| ISSN: | 1054-3406 |
| Date: | 2011 |
| Volume: | Vol.21 |
| Number: | No.4 |
| Page Range: | pp. 787-801 |
| Identification Number: | 10.1080/10543406.2011.551335 |
| Status: | Peer Reviewed |
| Publication Status: | Published |
| Access rights to Published version: | Restricted or Subscription Access |
| Description: | Special Issue: Dealing with multiplicity in drug development: current state and new directions |
| URI: | http://wrap.warwick.ac.uk/id/eprint/37347 |
Data sourced from Thomson Reuters' Web of Knowledge
Actions (login required)
![]() |
View Item |
Tools
Tools

